Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
LeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sagimet Biosciences (SGMT) Shares Outstanding (2022 - 2026)

Sagimet Biosciences' Shares Outstanding history spans 5 years, with the latest figure at $567494.0 for Q1 2026.

  • Quarterly Shares Outstanding fell 98.15% to $567494.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $567494.0 through Mar 2026, down 98.15% year-over-year, with the annual reading at $32.0 million for FY2025, 4.17% up from the prior year.
  • Shares Outstanding came in at $567494.0 for Q1 2026, down from $32.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $32.0 million in Q4 2025 to a low of $185084.0 in Q2 2022.
  • The 5-year median for Shares Outstanding is $1.5 million (2024), against an average of $10.9 million.
  • Year-over-year, Shares Outstanding skyrocketed 16321.41% in 2024 and then crashed 98.15% in 2026.
  • Sagimet Biosciences' Shares Outstanding stood at $185084.0 in 2022, then skyrocketed by 721.51% to $1.5 million in 2023, then skyrocketed by 1917.43% to $30.7 million in 2024, then grew by 4.17% to $32.0 million in 2025, then plummeted by 98.22% to $567494.0 in 2026.
  • Per Business Quant, the three most recent readings for SGMT's Shares Outstanding are $567494.0 (Q1 2026), $32.0 million (Q4 2025), and $31.0 million (Q3 2025).